Elizabeth Lee-Lewandrowski, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Point-of-Care Systems | 16 | 2016 | 1217 | 1.910 |
Why?
|
| Lyme Disease | 3 | 2023 | 627 | 1.400 |
Why?
|
| Tick-Borne Diseases | 2 | 2020 | 37 | 1.270 |
Why?
|
| Laboratories, Hospital | 8 | 2014 | 192 | 1.260 |
Why?
|
| Troponin T | 12 | 2011 | 786 | 1.140 |
Why?
|
| Running | 9 | 2008 | 489 | 0.870 |
Why?
|
| Borrelia | 1 | 2023 | 66 | 0.870 |
Why?
|
| Natriuretic Peptide, Brain | 13 | 2017 | 1749 | 0.850 |
Why?
|
| Myoglobin | 5 | 2006 | 158 | 0.800 |
Why?
|
| Ehrlichiosis | 2 | 2020 | 28 | 0.790 |
Why?
|
| Anaplasmosis | 2 | 2020 | 37 | 0.770 |
Why?
|
| Babesiosis | 2 | 2020 | 92 | 0.730 |
Why?
|
| Clinical Laboratory Techniques | 5 | 2017 | 746 | 0.700 |
Why?
|
| Creatine Kinase | 8 | 2007 | 683 | 0.690 |
Why?
|
| Disease Notification | 1 | 2020 | 95 | 0.650 |
Why?
|
| Antibodies, Bacterial | 2 | 2023 | 1477 | 0.570 |
Why?
|
| Peptide Fragments | 11 | 2017 | 5141 | 0.570 |
Why?
|
| Isoenzymes | 7 | 2005 | 1688 | 0.560 |
Why?
|
| Academic Medical Centers | 10 | 2018 | 2783 | 0.540 |
Why?
|
| Creatine Kinase, MB Form | 7 | 2006 | 202 | 0.520 |
Why?
|
| Urinalysis | 3 | 2010 | 369 | 0.490 |
Why?
|
| Influenza B virus | 1 | 2013 | 53 | 0.420 |
Why?
|
| Emergency Medical Services | 4 | 2011 | 1936 | 0.420 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 3 | 2009 | 425 | 0.410 |
Why?
|
| Laboratories | 3 | 2019 | 463 | 0.400 |
Why?
|
| Blood Donors | 2 | 2006 | 343 | 0.400 |
Why?
|
| Chest Pain | 3 | 2004 | 1101 | 0.390 |
Why?
|
| Reagent Kits, Diagnostic | 3 | 2016 | 238 | 0.380 |
Why?
|
| Shock | 3 | 2008 | 316 | 0.330 |
Why?
|
| Influenza A virus | 1 | 2013 | 455 | 0.330 |
Why?
|
| Occult Blood | 3 | 2010 | 199 | 0.330 |
Why?
|
| Troponin I | 4 | 2016 | 659 | 0.320 |
Why?
|
| Blood Chemical Analysis | 3 | 2009 | 434 | 0.320 |
Why?
|
| Length of Stay | 5 | 2009 | 6489 | 0.280 |
Why?
|
| Physical Endurance | 3 | 2007 | 369 | 0.270 |
Why?
|
| Clinical Chemistry Tests | 2 | 2008 | 59 | 0.260 |
Why?
|
| Creatinine | 1 | 2011 | 1916 | 0.250 |
Why?
|
| Health Planning Guidelines | 2 | 2005 | 152 | 0.240 |
Why?
|
| Pathology Department, Hospital | 1 | 2004 | 10 | 0.240 |
Why?
|
| Natriuretic Peptides | 1 | 2006 | 156 | 0.240 |
Why?
|
| Outsourced Services | 1 | 2004 | 20 | 0.230 |
Why?
|
| Biological Assay | 1 | 2007 | 626 | 0.230 |
Why?
|
| Donor Selection | 1 | 2006 | 242 | 0.230 |
Why?
|
| Sensitivity and Specificity | 10 | 2023 | 14672 | 0.220 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2005 | 120 | 0.220 |
Why?
|
| Utilization Review | 2 | 2004 | 381 | 0.220 |
Why?
|
| Intensive Care Units | 6 | 2017 | 3797 | 0.220 |
Why?
|
| Peroxidase | 1 | 2006 | 610 | 0.220 |
Why?
|
| Myocardial Ischemia | 2 | 2005 | 2131 | 0.210 |
Why?
|
| Myocardial Infarction | 5 | 2016 | 11513 | 0.200 |
Why?
|
| Medical History Taking | 1 | 2006 | 779 | 0.200 |
Why?
|
| Influenza, Human | 1 | 2013 | 1543 | 0.190 |
Why?
|
| Serologic Tests | 1 | 2023 | 382 | 0.190 |
Why?
|
| Serum Albumin | 1 | 2005 | 676 | 0.190 |
Why?
|
| Pregnancy Tests | 1 | 2001 | 33 | 0.190 |
Why?
|
| Blotting, Western | 2 | 2019 | 5022 | 0.190 |
Why?
|
| Coloring Agents | 1 | 2023 | 565 | 0.180 |
Why?
|
| Fish Oils | 1 | 2005 | 483 | 0.180 |
Why?
|
| Microbiology | 1 | 2001 | 70 | 0.180 |
Why?
|
| Colorado Tick Fever | 1 | 2020 | 5 | 0.170 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2020 | 19 | 0.170 |
Why?
|
| Relapsing Fever | 1 | 2020 | 25 | 0.170 |
Why?
|
| Total Quality Management | 1 | 2001 | 266 | 0.170 |
Why?
|
| Tularemia | 1 | 2020 | 40 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2006 | 1308 | 0.160 |
Why?
|
| Coronary Artery Bypass | 3 | 2004 | 2189 | 0.160 |
Why?
|
| Coronary Disease | 4 | 2007 | 5914 | 0.160 |
Why?
|
| Quality Assurance, Health Care | 5 | 2004 | 2174 | 0.160 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 1527 | 0.160 |
Why?
|
| Troponin | 1 | 2002 | 536 | 0.150 |
Why?
|
| Endemic Diseases | 1 | 2018 | 190 | 0.140 |
Why?
|
| Predictive Value of Tests | 10 | 2017 | 15424 | 0.140 |
Why?
|
| Blood Glucose | 3 | 2010 | 6421 | 0.140 |
Why?
|
| Drug Prescriptions | 1 | 2006 | 1664 | 0.140 |
Why?
|
| Heart Diseases | 3 | 2009 | 2817 | 0.130 |
Why?
|
| Humans | 59 | 2023 | 767040 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 3804 | 0.130 |
Why?
|
| Electrolytes | 1 | 2017 | 279 | 0.130 |
Why?
|
| Reference Values | 6 | 2008 | 4918 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2009 | 1883 | 0.130 |
Why?
|
| Emergencies | 1 | 2002 | 1223 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 1 | 2019 | 1697 | 0.130 |
Why?
|
| Emergency Service, Hospital | 6 | 2016 | 7871 | 0.130 |
Why?
|
| Magnesium | 2 | 2017 | 815 | 0.120 |
Why?
|
| New England | 1 | 2018 | 1058 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2005 | 1399 | 0.120 |
Why?
|
| Critical Illness | 2 | 2017 | 2753 | 0.120 |
Why?
|
| Middle Aged | 24 | 2020 | 223233 | 0.120 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 59548 | 0.120 |
Why?
|
| Dyspnea | 3 | 2007 | 1352 | 0.110 |
Why?
|
| Ambulatory Care | 3 | 2014 | 2780 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2013 | 65 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2003 | 2463 | 0.110 |
Why?
|
| Blood Specimen Collection | 1 | 1994 | 238 | 0.110 |
Why?
|
| RNA | 1 | 2022 | 2715 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2017 | 700 | 0.100 |
Why?
|
| Pathology, Clinical | 2 | 2014 | 374 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2005 | 3446 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 4560 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2002 | 1564 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2022 | 2464 | 0.090 |
Why?
|
| Adult | 18 | 2020 | 223317 | 0.090 |
Why?
|
| Inpatients | 1 | 2002 | 2563 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2020 | 42606 | 0.090 |
Why?
|
| Algorithms | 2 | 2023 | 14098 | 0.090 |
Why?
|
| Hyponatremia | 3 | 2008 | 279 | 0.090 |
Why?
|
| Critical Care | 2 | 2017 | 2714 | 0.080 |
Why?
|
| Blood Coagulation Tests | 1 | 2010 | 269 | 0.080 |
Why?
|
| Aged | 16 | 2020 | 171319 | 0.080 |
Why?
|
| Guaiac | 1 | 2008 | 13 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 683 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2009 | 177 | 0.080 |
Why?
|
| Hospitals, Urban | 1 | 2009 | 495 | 0.070 |
Why?
|
| Heart Failure | 6 | 2007 | 11877 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 2257 | 0.070 |
Why?
|
| Physical Exertion | 2 | 2008 | 667 | 0.070 |
Why?
|
| Enzyme Multiplied Immunoassay Technique | 1 | 2006 | 7 | 0.070 |
Why?
|
| Promethazine | 1 | 2006 | 29 | 0.070 |
Why?
|
| Arginine Vasopressin | 1 | 2007 | 125 | 0.070 |
Why?
|
| Male | 24 | 2017 | 364203 | 0.070 |
Why?
|
| Time Factors | 5 | 2011 | 40154 | 0.070 |
Why?
|
| Adolescent | 5 | 2020 | 89046 | 0.070 |
Why?
|
| Young Adult | 3 | 2020 | 59980 | 0.070 |
Why?
|
| Myocardial Stunning | 1 | 2006 | 67 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2004 | 15824 | 0.070 |
Why?
|
| Time | 1 | 2008 | 551 | 0.070 |
Why?
|
| Monitoring, Ambulatory | 1 | 2009 | 357 | 0.060 |
Why?
|
| General Surgery | 1 | 2017 | 1720 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4572 | 0.060 |
Why?
|
| Teratogens | 1 | 2006 | 119 | 0.060 |
Why?
|
| Amphetamine | 1 | 2006 | 222 | 0.060 |
Why?
|
| False Positive Reactions | 2 | 2006 | 959 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 429 | 0.060 |
Why?
|
| Serum | 1 | 2006 | 206 | 0.060 |
Why?
|
| Child | 3 | 2020 | 80771 | 0.060 |
Why?
|
| Capillaries | 2 | 2001 | 755 | 0.060 |
Why?
|
| Northwestern United States | 1 | 2004 | 20 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2017 | 54886 | 0.060 |
Why?
|
| Female | 22 | 2017 | 396660 | 0.060 |
Why?
|
| Pulmonary Embolism | 2 | 2009 | 2598 | 0.060 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 5180 | 0.060 |
Why?
|
| Acute Disease | 4 | 2007 | 7236 | 0.060 |
Why?
|
| Pesticide Residues | 1 | 2005 | 95 | 0.060 |
Why?
|
| Sample Size | 1 | 2007 | 845 | 0.060 |
Why?
|
| Substance Abuse Detection | 1 | 2006 | 301 | 0.060 |
Why?
|
| Decision Making, Organizational | 1 | 2004 | 136 | 0.050 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 405 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 2193 | 0.050 |
Why?
|
| Sodium | 2 | 2008 | 1594 | 0.050 |
Why?
|
| Boston | 5 | 2006 | 9360 | 0.050 |
Why?
|
| Necrosis | 2 | 2005 | 1614 | 0.050 |
Why?
|
| Incidence | 2 | 2018 | 21526 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2020 | 26396 | 0.050 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2005 | 235 | 0.050 |
Why?
|
| Myocardium | 2 | 2006 | 4765 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2017 | 2666 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5886 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 2227 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2006 | 744 | 0.050 |
Why?
|
| Mercury | 1 | 2005 | 289 | 0.050 |
Why?
|
| Patient Admission | 1 | 2009 | 1364 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 20169 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2002 | 404 | 0.050 |
Why?
|
| Hematologic Tests | 1 | 2002 | 239 | 0.050 |
Why?
|
| Urban Population | 1 | 2009 | 2044 | 0.050 |
Why?
|
| Hospital Costs | 2 | 2004 | 956 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2006 | 645 | 0.040 |
Why?
|
| Electrocardiography | 2 | 2005 | 6409 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 2004 | 372 | 0.040 |
Why?
|
| American Heart Association | 1 | 2005 | 1049 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2009 | 1321 | 0.040 |
Why?
|
| Commerce | 1 | 2005 | 614 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 2002 | 458 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5389 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2002 | 892 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2005 | 1540 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2002 | 680 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 1168 | 0.040 |
Why?
|
| Infant | 1 | 2020 | 36485 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 1097 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2013 | 18989 | 0.040 |
Why?
|
| Neoplasms | 2 | 2022 | 22350 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2001 | 1142 | 0.030 |
Why?
|
| Specialization | 1 | 2001 | 778 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2006 | 1245 | 0.030 |
Why?
|
| Massachusetts | 3 | 2004 | 8890 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2004 | 1997 | 0.030 |
Why?
|
| Hospitals | 1 | 2008 | 3883 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2001 | 1396 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 2764 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2912 | 0.030 |
Why?
|
| Physician Executives | 1 | 2014 | 140 | 0.030 |
Why?
|
| Work | 1 | 2014 | 195 | 0.030 |
Why?
|
| Prognosis | 4 | 2007 | 29963 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13491 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4401 | 0.020 |
Why?
|
| Meglumine | 1 | 1992 | 144 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2018 | 81659 | 0.020 |
Why?
|
| Forecasting | 1 | 2001 | 2936 | 0.020 |
Why?
|
| Multivariate Analysis | 4 | 2007 | 12069 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 4422 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2002 | 2099 | 0.020 |
Why?
|
| Efficiency | 1 | 2014 | 479 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2017 | 1480 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 2144 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2002 | 3851 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2014 | 804 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 1994 | 1156 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 861 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2017 | 41718 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2850 | 0.020 |
Why?
|
| Cost Savings | 1 | 2014 | 904 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2004 | 3683 | 0.020 |
Why?
|
| Immunochemistry | 1 | 2008 | 116 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2017 | 8732 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3236 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2007 | 189 | 0.020 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2007 | 59 | 0.020 |
Why?
|
| Acidosis, Lactic | 1 | 2008 | 144 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2007 | 861 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5446 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5311 | 0.020 |
Why?
|
| Prolactin | 1 | 2007 | 627 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3667 | 0.010 |
Why?
|
| United States | 2 | 2005 | 72971 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2006 | 828 | 0.010 |
Why?
|
| Hypernatremia | 1 | 2005 | 78 | 0.010 |
Why?
|
| Diastole | 1 | 2006 | 784 | 0.010 |
Why?
|
| Stroke | 1 | 2006 | 9746 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 87 | 0.010 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2005 | 111 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 654 | 0.010 |
Why?
|
| Immunoassay | 1 | 2007 | 744 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1531 | 0.010 |
Why?
|
| Dehydration | 1 | 2005 | 216 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 633 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2004 | 456 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2008 | 1139 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2004 | 338 | 0.010 |
Why?
|
| HIV Infections | 1 | 2009 | 17542 | 0.010 |
Why?
|
| Brain Edema | 1 | 2007 | 601 | 0.010 |
Why?
|
| Risk | 2 | 2007 | 9606 | 0.010 |
Why?
|
| Body Fluids | 1 | 2004 | 321 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2004 | 10092 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9532 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2008 | 1126 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2008 | 1409 | 0.010 |
Why?
|
| Endosonography | 1 | 2004 | 626 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2006 | 8531 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1824 | 0.010 |
Why?
|
| Pregnancy | 1 | 2001 | 30238 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2004 | 697 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1840 | 0.010 |
Why?
|
| ROC Curve | 1 | 2007 | 3618 | 0.010 |
Why?
|
| Physical Examination | 1 | 2005 | 1265 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 2616 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2350 | 0.010 |
Why?
|
| Inflammation | 1 | 2017 | 10869 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2698 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3227 | 0.010 |
Why?
|
| Linear Models | 1 | 2007 | 5875 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 3431 | 0.010 |
Why?
|
| Risk Factors | 2 | 2017 | 74886 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 39317 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5792 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 6331 | 0.010 |
Why?
|
| Buffers | 1 | 1992 | 141 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1992 | 291 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 1992 | 218 | 0.010 |
Why?
|
| Propanolamines | 1 | 1992 | 164 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 13284 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 12986 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9245 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1992 | 2478 | 0.000 |
Why?
|
| Temperature | 1 | 1992 | 2232 | 0.000 |
Why?
|
| Kinetics | 1 | 1992 | 6287 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20741 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2004 | 24299 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1992 | 8310 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2004 | 65295 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 15645 | 0.000 |
Why?
|